Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions

Paul Cairns, Kenji Okami, Peter King, Julia Bonacum, Steve Ahrendt, Li Wu, Li Mao, Jin Jen, David Sidransky

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Allelic loss of chromosome 9p21 is common in small cell lung cancer (SCLC), but inactivation of the tumor suppressor gene CDKN2a is rare, implying the existence of another target gene at 9p21. A recent deletion mapping study of chromosome 9p has also identified a site of deletion in non- small cell lung cancer (NSCLC) centered around D9S126. The Hel-N1 (human elav-like neuronal protein I) gene encodes a neural-specific RNA binding protein that is expressed in SCLC. We have mapped this potentially important gene in lung tumorigenesis to within 100 kb of the D9S126 marker at chromosome band 9p21 by using homozygously deleted tumor cell lines and fluorescence in situ hybridization to normal metaphase spreads. Hel-N1 is, therefore, a candidate target suppressor gene in both SCLC and NSCLC. We have determined the genomic organization and intron/exon boundaries of Hel-N1 and have screened the entire coding region for mutations by sequencing 14 primary SCLCs and cell lines and 21 primary NSCLCs preselected for localized 9p21 deletion or monosomy of chromosome 9. A homozygous deletion including Hel-N1 and CDKN2a was found in a SCLC cell line, and a single-base polymorphism in exon 2 of Hel-N1 was observed in eight tumors. No somatic mutations of Hel- N1 were found in this panel of lung tumors. Hel-N1 does not appear to be a primary inactivation target of 9p21 deletion in lung cancer.

Original languageEnglish (US)
Pages (from-to)5356-5359
Number of pages4
JournalCancer Research
Volume57
Issue number23
StatePublished - Dec 1 1997
Externally publishedYes

Fingerprint

Chromosome Deletion
Small Cell Lung Carcinoma
Lung Neoplasms
Mutation
Non-Small Cell Lung Carcinoma
Exons
Suppressor Genes
Monosomy
Cell Line
Lung
Chromosomes, Human, Pair 9
RNA-Binding Proteins
Loss of Heterozygosity
Chromosome Mapping
Metaphase
Tumor Cell Line
Tumor Suppressor Genes
Fluorescence In Situ Hybridization
Genetic Markers
Introns

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cairns, P., Okami, K., King, P., Bonacum, J., Ahrendt, S., Wu, L., ... Sidransky, D. (1997). Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. Cancer Research, 57(23), 5356-5359.

Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. / Cairns, Paul; Okami, Kenji; King, Peter; Bonacum, Julia; Ahrendt, Steve; Wu, Li; Mao, Li; Jen, Jin; Sidransky, David.

In: Cancer Research, Vol. 57, No. 23, 01.12.1997, p. 5356-5359.

Research output: Contribution to journalArticle

Cairns, P, Okami, K, King, P, Bonacum, J, Ahrendt, S, Wu, L, Mao, L, Jen, J & Sidransky, D 1997, 'Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions', Cancer Research, vol. 57, no. 23, pp. 5356-5359.
Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L et al. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. Cancer Research. 1997 Dec 1;57(23):5356-5359.
Cairns, Paul ; Okami, Kenji ; King, Peter ; Bonacum, Julia ; Ahrendt, Steve ; Wu, Li ; Mao, Li ; Jen, Jin ; Sidransky, David. / Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. In: Cancer Research. 1997 ; Vol. 57, No. 23. pp. 5356-5359.
@article{f7ccade9f5fd426ab2c350059708c226,
title = "Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions",
abstract = "Allelic loss of chromosome 9p21 is common in small cell lung cancer (SCLC), but inactivation of the tumor suppressor gene CDKN2a is rare, implying the existence of another target gene at 9p21. A recent deletion mapping study of chromosome 9p has also identified a site of deletion in non- small cell lung cancer (NSCLC) centered around D9S126. The Hel-N1 (human elav-like neuronal protein I) gene encodes a neural-specific RNA binding protein that is expressed in SCLC. We have mapped this potentially important gene in lung tumorigenesis to within 100 kb of the D9S126 marker at chromosome band 9p21 by using homozygously deleted tumor cell lines and fluorescence in situ hybridization to normal metaphase spreads. Hel-N1 is, therefore, a candidate target suppressor gene in both SCLC and NSCLC. We have determined the genomic organization and intron/exon boundaries of Hel-N1 and have screened the entire coding region for mutations by sequencing 14 primary SCLCs and cell lines and 21 primary NSCLCs preselected for localized 9p21 deletion or monosomy of chromosome 9. A homozygous deletion including Hel-N1 and CDKN2a was found in a SCLC cell line, and a single-base polymorphism in exon 2 of Hel-N1 was observed in eight tumors. No somatic mutations of Hel- N1 were found in this panel of lung tumors. Hel-N1 does not appear to be a primary inactivation target of 9p21 deletion in lung cancer.",
author = "Paul Cairns and Kenji Okami and Peter King and Julia Bonacum and Steve Ahrendt and Li Wu and Li Mao and Jin Jen and David Sidransky",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "57",
pages = "5356--5359",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions

AU - Cairns, Paul

AU - Okami, Kenji

AU - King, Peter

AU - Bonacum, Julia

AU - Ahrendt, Steve

AU - Wu, Li

AU - Mao, Li

AU - Jen, Jin

AU - Sidransky, David

PY - 1997/12/1

Y1 - 1997/12/1

N2 - Allelic loss of chromosome 9p21 is common in small cell lung cancer (SCLC), but inactivation of the tumor suppressor gene CDKN2a is rare, implying the existence of another target gene at 9p21. A recent deletion mapping study of chromosome 9p has also identified a site of deletion in non- small cell lung cancer (NSCLC) centered around D9S126. The Hel-N1 (human elav-like neuronal protein I) gene encodes a neural-specific RNA binding protein that is expressed in SCLC. We have mapped this potentially important gene in lung tumorigenesis to within 100 kb of the D9S126 marker at chromosome band 9p21 by using homozygously deleted tumor cell lines and fluorescence in situ hybridization to normal metaphase spreads. Hel-N1 is, therefore, a candidate target suppressor gene in both SCLC and NSCLC. We have determined the genomic organization and intron/exon boundaries of Hel-N1 and have screened the entire coding region for mutations by sequencing 14 primary SCLCs and cell lines and 21 primary NSCLCs preselected for localized 9p21 deletion or monosomy of chromosome 9. A homozygous deletion including Hel-N1 and CDKN2a was found in a SCLC cell line, and a single-base polymorphism in exon 2 of Hel-N1 was observed in eight tumors. No somatic mutations of Hel- N1 were found in this panel of lung tumors. Hel-N1 does not appear to be a primary inactivation target of 9p21 deletion in lung cancer.

AB - Allelic loss of chromosome 9p21 is common in small cell lung cancer (SCLC), but inactivation of the tumor suppressor gene CDKN2a is rare, implying the existence of another target gene at 9p21. A recent deletion mapping study of chromosome 9p has also identified a site of deletion in non- small cell lung cancer (NSCLC) centered around D9S126. The Hel-N1 (human elav-like neuronal protein I) gene encodes a neural-specific RNA binding protein that is expressed in SCLC. We have mapped this potentially important gene in lung tumorigenesis to within 100 kb of the D9S126 marker at chromosome band 9p21 by using homozygously deleted tumor cell lines and fluorescence in situ hybridization to normal metaphase spreads. Hel-N1 is, therefore, a candidate target suppressor gene in both SCLC and NSCLC. We have determined the genomic organization and intron/exon boundaries of Hel-N1 and have screened the entire coding region for mutations by sequencing 14 primary SCLCs and cell lines and 21 primary NSCLCs preselected for localized 9p21 deletion or monosomy of chromosome 9. A homozygous deletion including Hel-N1 and CDKN2a was found in a SCLC cell line, and a single-base polymorphism in exon 2 of Hel-N1 was observed in eight tumors. No somatic mutations of Hel- N1 were found in this panel of lung tumors. Hel-N1 does not appear to be a primary inactivation target of 9p21 deletion in lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=0030696718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030696718&partnerID=8YFLogxK

M3 - Article

C2 - 9393760

AN - SCOPUS:0030696718

VL - 57

SP - 5356

EP - 5359

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 23

ER -